Ironwood Pharmaceuticals (IRWD) Total Current Liabilities (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Total Current Liabilities data on file, last reported at $236.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 391.31% year-over-year to $236.3 million; the trailing twelve-month figure through Mar 2026 stood at $236.3 million (up 391.31% YoY), and the FY2025 full-year result was $242.2 million, up 523.53% from the prior year.
• Total Current Liabilities eased to $236.3 million in Q1 2026, from $242.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $305.4 million in Q2 2023 to a low of $23.3 million in Q2 2022.
• A 5-year average of $146.9 million and a median of $147.4 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 1210.8% in 2023 and plunged 85.93% in 2024, its largest moves.
• Tracing IRWD's Total Current Liabilities over 5 years: stood at $25.5 million in 2022, then jumped by 981.69% to $276.1 million in 2023, then sank by 85.93% to $38.8 million in 2024, then surged by 523.53% to $242.2 million in 2025, then declined by 2.44% to $236.3 million in 2026.
• Business Quant data shows IRWD's Total Current Liabilities at $236.3 million in Q1 2026, $242.2 million in Q4 2025, and $242.5 million in Q3 2025.